BioAge Labs, Inc Financial Flexibility Index
BioAge Labs, Inc financial flexibility index. BioAge Labs, Inc (BIOA) has a Financial Flexibility Index of -0.86x as of June 2026. Free cash flow of $-18.93 Million (operating CF $-19.26 Million minus capex $328.00K) represents -1% of total liabilities ($22.02 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of BioAge Labs, Inc (2013–2025)
Financial flexibility index of BioAge Labs, Inc from 2013 to 2025. Historical Financial Flexibility Index trend for BioAge Labs, Inc across 9 annual periods. Check BioAge Labs, Inc earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
BioAge Labs, Inc Financial Flexibility Index by Year (2013–2025)
BioAge Labs, Inc financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for BioAge Labs, Inc. For the full cash flow conversion analysis, see BioAge Labs, Inc operating cash flow efficiency.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.54x | $-80.91 Million | $-81.63 Million | $22.84 Million | ▼ -143.1% |
| 2024 | -1.46x | $-51.16 Million | $-51.52 Million | $35.11 Million | ▼ -680.8% |
| 2023 | -0.19x | $-37.20 Million | $-37.36 Million | $199.32 Million | ▲ +27.1% |
| 2022 | -0.26x | $-36.08 Million | $-36.18 Million | $140.99 Million | ▲ +59.1% |
| 2017 | -0.63x | $-29.79 Million | $-29.79 Million | $47.66 Million | ▼ -87.5% |
| 2016 | -0.33x | $-37.62 Million | $-37.62 Million | $112.84 Million | ▼ -0.1% |
| 2015 | -0.33x | $-32.20 Million | $-32.20 Million | $96.73 Million | ▼ -40.7% |
| 2014 | -0.24x | $-22.45 Million | $-22.45 Million | $94.91 Million | ▲ +21.2% |
| 2013 | -0.30x | $-14.74 Million | $-27.52 Million | $49.07 Million | — |